FDA Clears AI Software for Subtype-Specific Sleep Apnea Classification

FDA has cleared HoneyNaps' SOMNUM V3.0, an AI software that automatically classifies sleep apnea subtypes (obstructive, central, mixed) from polysomnography data with 97%+ agreement, enabling more precise diagnostic scoring than manual analysis. If you're building sleep diagnostics or any clinical AI that competes with manual scoring, subtype-level classification just became the regulatory floor. HoneyNaps' 510(k) path—validation via algorithmic accuracy rather than clinical outcome trials—is now a proven route to market; build to that standard and you can follow the same clearance track.